Notice Information
Notice Title
Pathology Managed Service for Midlands & East 2 Network
Notice Description
The Midlands and East 2 Network (the "ME2 Network") is a network-wide pathology collaboration in the Midlands and East 2 region, comprising the Contracting Authorities listed in this notice. The ME2 Network carried out a further competition for a pathology managed service under the NHS Supply Chain Laboratory Diagnostics, Point of Care Testing and Pathology Managed Service Framework in accordance with the Public Contracts Regulations 2015. This contract award notice covers the contract for a pathology managed service awarded by the contracting authority in section I.1 of this notice
Lot Information
Lot 1
The Midlands East 2 Pathology Network is made of the following NHS Trusts: University Hospitals of Derby and Burton NHS Foundation Trust; Chesterfield Royal Hospital NHS Foundation Trust; Kettering General Hospital NHS Foundation Trust; Northampton General Hospital NHS Trust; University Hospitals of Leicester NHS Trust; Nottingham University Hospitals NHS Trust; Sherwood Forest Hospitals NHS Foundation Trust; United Lincolnshire Hospitals NHS Trust; and Northern Lincolnshire and Goole NHS Foundation Trust ("ME2 Network"). The ME2 Network carried out a further competition under Lot 1 of the NHS Supply Chain Framework Agreement for Laboratory Diagnostics, Point of Care Testing and Pathology Managed Services (Framework reference number 2023 S/00 028831) to select a pathology managed service provider (the "Successful Supplier"). Kettering General Hospital NHS Foundation Trust has entered into its own contract with the Successful Supplier. This contract award notice is being published by Kettering General Hospital NHS Foundation Trust. The other NHS Trusts listed as part of the ME2 Network have also entered into separate contracts with the Successful Supplier although note that Northern Lincolnshire and Goole NHS Foundation Trust will enter into its contract for and on behalf of itself and United Lincolnshire Hospitals NHS Trust as the "Path Links" arrangement and this also includes pathology provision at Grimsby, Scunthorpe, Lincoln, Boston and Grantham hospitals and "Derbyshire Pathology" is hosted by University Hospitals of Derby and Burton NHS Foundation Trust, which includes Derby, Burton and Chesterfield Pathology services. The contract includes Phase 1 services: general managed services, biochemistry (including some elements of immunology and serology) and haematology services (including coagulation), pre and post analytical equipment with associated IT and middleware; and Phase 2 services: immunology, blood transfusion, POCT, specialist biochemistry, specialist haematology, cellular pathology (histopathology and mortuary), microbiology (molecular microbiology, bacteriology, serology (including virology)). In accordance with the terms of the contract, the Successful Supplier is responsible for the provision of Phase 1 services in accordance with the implementation plans set out in the contract. The initial ten (10) year term will begin from the ME2 Network Actual Services Commencement Date (the date that the first of the ME2 Network contracts actually commences the delivery of all Phase 1 Services). The term of the contract may be extended for up to 2 years. The Successful Supplier is required to work in collaboration with the ME2 Network to fully develop each of the NHS Trusts' requirements for phase 2 sub-disciplines, test the market and award the winning supplier (a sub-contractor) to provide the relevant Phase 2 service discipline, to ensure value for money and quality of delivery. The Successful Supplier will be responsible for fully managing its sub-contractors under the terms of the contract. The contract sets out the process and governance arrangements for initiating and delivering phase 2 services. The contract value of the Phase 1 services is approximately PS13 million. It is anticipated that the contract value of both Phase 1 and Phase 2 services shall be somewhere between PS13 million and PS45 million Additional information: The value of the contract referred to in section II.I.7 refers to the contract value of the Phase 1 services which is approximately PS13 million. It is anticipated that the contract value of both Phase 1 and Phase 2 services shall be somewhere between PS13 million and PS45 million
Options: The initial ten (10) year term will begin from the ME2 Network Actual Services Commencement Date (the date that the first of the ME2 Network contracts actually commences the delivery of all Phase 1 Services). The term of the contract may be extended for up to 2 years.
Procurement Information
The contract was awarded following a further competition under Lot 1 of the NHS Supply Chain Framework Agreement for Laboratory Diagnostics, Point of Care Testing and Pathology Managed Services (Framework reference number 2023 S/00 028831) in accordance with the Public Contracts Regulations 2015 ("PCR"). There was therefore no prior publication of a notice and this contract award notice is being published for transparency as there is no obligation to publish a contract award notice following a further competition under a Framework Agreement under the PCR.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-06c336
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/062698-2026
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
-
- CPV Codes
85111800 - Pathology services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £13,000,000 £10M-£100M
Notice Dates
- Publication Date
- 3 Jul 20261 weeks ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 3 Jun 20261 months ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- KETTERING GENERAL HOSPITAL NHS FOUNDATION TRUST
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- KETTERING
- Postcode
- NN16 8UZ
- Post Town
- Northampton
- Country
- England
-
- Major Region (ITL 1)
- TLF East Midlands (England)
- Basic Region (ITL 2)
- TLF2 Leicestershire, Rutland and Northamptonshire
- Small Region (ITL 3)
- TLF25 North Northamptonshire
- Delivery Location
- Not specified
-
- Local Authority
- North Northamptonshire
- Electoral Ward
- Northall
- Westminster Constituency
- Kettering
Further Information
Notice URLs
Open Contracting Data Standard (OCDS)
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-06c336-2026-07-03T11:37:50+01:00",
"date": "2026-07-03T11:37:50+01:00",
"ocid": "ocds-h6vhtk-06c336",
"initiationType": "tender",
"tender": {
"id": "ocds-h6vhtk-06c336",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Pathology Managed Service for Midlands & East 2 Network",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "85111800",
"description": "Pathology services"
},
"mainProcurementCategory": "services",
"description": "The Midlands and East 2 Network (the \"ME2 Network\") is a network-wide pathology collaboration in the Midlands and East 2 region, comprising the Contracting Authorities listed in this notice. The ME2 Network carried out a further competition for a pathology managed service under the NHS Supply Chain Laboratory Diagnostics, Point of Care Testing and Pathology Managed Service Framework in accordance with the Public Contracts Regulations 2015. This contract award notice covers the contract for a pathology managed service awarded by the contracting authority in section I.1 of this notice",
"lots": [
{
"id": "1",
"description": "The Midlands East 2 Pathology Network is made of the following NHS Trusts: University Hospitals of Derby and Burton NHS Foundation Trust; Chesterfield Royal Hospital NHS Foundation Trust; Kettering General Hospital NHS Foundation Trust; Northampton General Hospital NHS Trust; University Hospitals of Leicester NHS Trust; Nottingham University Hospitals NHS Trust; Sherwood Forest Hospitals NHS Foundation Trust; United Lincolnshire Hospitals NHS Trust; and Northern Lincolnshire and Goole NHS Foundation Trust (\"ME2 Network\"). The ME2 Network carried out a further competition under Lot 1 of the NHS Supply Chain Framework Agreement for Laboratory Diagnostics, Point of Care Testing and Pathology Managed Services (Framework reference number 2023 S/00 028831) to select a pathology managed service provider (the \"Successful Supplier\"). Kettering General Hospital NHS Foundation Trust has entered into its own contract with the Successful Supplier. This contract award notice is being published by Kettering General Hospital NHS Foundation Trust. The other NHS Trusts listed as part of the ME2 Network have also entered into separate contracts with the Successful Supplier although note that Northern Lincolnshire and Goole NHS Foundation Trust will enter into its contract for and on behalf of itself and United Lincolnshire Hospitals NHS Trust as the \"Path Links\" arrangement and this also includes pathology provision at Grimsby, Scunthorpe, Lincoln, Boston and Grantham hospitals and \"Derbyshire Pathology\" is hosted by University Hospitals of Derby and Burton NHS Foundation Trust, which includes Derby, Burton and Chesterfield Pathology services. The contract includes Phase 1 services: general managed services, biochemistry (including some elements of immunology and serology) and haematology services (including coagulation), pre and post analytical equipment with associated IT and middleware; and Phase 2 services: immunology, blood transfusion, POCT, specialist biochemistry, specialist haematology, cellular pathology (histopathology and mortuary), microbiology (molecular microbiology, bacteriology, serology (including virology)). In accordance with the terms of the contract, the Successful Supplier is responsible for the provision of Phase 1 services in accordance with the implementation plans set out in the contract. The initial ten (10) year term will begin from the ME2 Network Actual Services Commencement Date (the date that the first of the ME2 Network contracts actually commences the delivery of all Phase 1 Services). The term of the contract may be extended for up to 2 years. The Successful Supplier is required to work in collaboration with the ME2 Network to fully develop each of the NHS Trusts' requirements for phase 2 sub-disciplines, test the market and award the winning supplier (a sub-contractor) to provide the relevant Phase 2 service discipline, to ensure value for money and quality of delivery. The Successful Supplier will be responsible for fully managing its sub-contractors under the terms of the contract. The contract sets out the process and governance arrangements for initiating and delivering phase 2 services. The contract value of the Phase 1 services is approximately PS13 million. It is anticipated that the contract value of both Phase 1 and Phase 2 services shall be somewhere between PS13 million and PS45 million Additional information: The value of the contract referred to in section II.I.7 refers to the contract value of the Phase 1 services which is approximately PS13 million. It is anticipated that the contract value of both Phase 1 and Phase 2 services shall be somewhere between PS13 million and PS45 million",
"awardCriteria": {
"criteria": [
{
"name": "Commercial",
"type": "cost",
"description": "30%"
}
]
},
"hasOptions": true,
"options": {
"description": "The initial ten (10) year term will begin from the ME2 Network Actual Services Commencement Date (the date that the first of the ME2 Network contracts actually commences the delivery of all Phase 1 Services). The term of the contract may be extended for up to 2 years."
},
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"id": "D_OUTSIDE_SCOPE",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"description": "The procurement falls outside the scope of application of the directive"
}
],
"procurementMethodRationale": "The contract was awarded following a further competition under Lot 1 of the NHS Supply Chain Framework Agreement for Laboratory Diagnostics, Point of Care Testing and Pathology Managed Services (Framework reference number 2023 S/00 028831) in accordance with the Public Contracts Regulations 2015 (\"PCR\"). There was therefore no prior publication of a notice and this contract award notice is being published for transparency as there is no obligation to publish a contract award notice following a further competition under a Framework Agreement under the PCR."
},
"awards": [
{
"id": "062698-2026-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-COH-00571546",
"name": "Roche Diagnostics Ltd"
}
]
}
],
"parties": [
{
"id": "GB-NHS-RJZ",
"name": "KETTERING GENERAL HOSPITAL NHS FOUNDATION TRUST",
"identifier": {
"legalName": "KETTERING GENERAL HOSPITAL NHS FOUNDATION TRUST",
"id": "RJZ",
"scheme": "GB-NHS"
},
"address": {
"streetAddress": "Rothwell Rd",
"locality": "Kettering",
"region": "UKF25",
"postalCode": "NN168UZ",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "ngh-tr.supplies.dept@nhs.net"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.kgh.nhs.uk",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
}
},
{
"id": "GB-COH-00571546",
"name": "Roche Diagnostics Ltd",
"identifier": {
"legalName": "Roche Diagnostics Ltd",
"id": "00571546",
"scheme": "GB-COH"
},
"address": {
"locality": "Burgess Hill",
"region": "UKJ2",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-495",
"name": "The High Court",
"identifier": {
"legalName": "The High Court"
},
"address": {
"locality": "London",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-NHS-RJZ",
"name": "KETTERING GENERAL HOSPITAL NHS FOUNDATION TRUST"
},
"contracts": [
{
"id": "062698-2026-1",
"awardID": "062698-2026-1",
"status": "active",
"value": {
"amount": 13000000,
"currency": "GBP"
},
"dateSigned": "2026-06-04T00:00:00+01:00"
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 1
}
]
},
"language": "en"
}